CFHR4 and age-related macular degeneration: Based on our in vitro competition assays (Fig. 2j), we propose that in AMD the accumulation of FHR-4 in the ECM out-competes FHL-1 for C3b binding, thereby preventing FI-mediated C3b breakdown and driving complement activation.